Figure 1
From: NTN4 as a prognostic marker and a hallmark for immune infiltration in breast cancer
NTN4 expression and clinicopathological features of breast cancer. (A) NTN4 mRNA expression levels in different tumor types from TCGA database were determined by TIMER (*P < 0.05, **P < 0.01, ***P < 0.001). (B) Wilcoxon rank sum test was used to analyze differential expression of NTN4 between BC tumor and adjacent tissue. (C) Wilcoxon signed rank sum test was used to detect the differential expression of NTN4 between BC tumor and adjacent tissue. (D) ROC curve established efficiency of NTN4 mRNA expression level on distinguishing BC tumor from non-tumor tissue. X-axis represents false positive rate, and Y-axis represents true positive rate. (E): Representative negative (adjacent tissue) and positive (breast tumor tissue) expression of NTN4 protein as demonstrated by IHC. The magnification is 100 × (upper) or 200 × (lower), respectively.
